Pioneered Thermo-Acoustic Enhanced Ultrasound (TAEUS®), a disruptive platform enabling MRI-like characterization of tissue at 40X lower cost, at the point of patient care. Led startup from concept to clinical stage, defining strategy and overseeing operations of global staff in R&D, RA/QA, finance, operations, marketing and HR. • Raised $73M through a Nasdaq IPO and follow-on rounds• Published first-in-human data and secured CE Mark for first TAEUS application quantifying liver fat as a biomarker for metabolic disease• Grew IP portfolio from 2 to 81 patents, 3X peer group average• Forged strategic & clinical partnerships — including GE Healthcare, King's College London, and Shanghai General — to accelerate technology adoption

Revitalized commercial strategy of a $255M PE-backed dental implant provider by enhancing sales channels and introducing value-driven offerings, while sustaining premium positioning through innovation and training services• Reversed multi-year sales declines to positive growth

Led a $125M surgical products/services P&L, overseeing three global service centers and 75 cross-functional staff• Built a new service business, scaling it to $55 million with double-digit EBITDA margins• Transformed a $70 million surgical imaging business, boosting EBITDA 150%

Grew a $300M X-ray business 8% CAGR — 50% above market rate — and increased gross margin 9 percentage points